BIOMAT Database Logo BIOMAT Database Logo

Fibrin-fibrinogen degradation products in hepatic cirrhosis. 1977

M Bulajić, and N Kovacević, and M Lalić, and Z Rolović

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
[Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
January 1972, Sangre,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis.
January 1973, Scandinavian journal of haematology,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
Fibrinogen-fibrin degradation products.
January 1980, Annals of clinical and laboratory science,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
[Fibrin/fibrinogen degradation products (FDP)].
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
[Fibrin and fibrinogen degradation products].
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
[Fibrin/fibrinogen degradation products (FDP)].
December 1989, Nihon rinsho. Japanese journal of clinical medicine,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
[Fibrinogen and fibrin degradation products].
January 1973, Rinsho byori. The Japanese journal of clinical pathology,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
Fibrin/fibrinogen degradation products in glomerulonephritis.
September 1971, British medical journal,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
Fibrinogen, fibrin degradation products and fibrinolysis in bilharzial (schistosomal) hepatic fibrosis.
January 1977, Transactions of the Royal Society of Tropical Medicine and Hygiene,
M Bulajić, and N Kovacević, and M Lalić, and Z Rolović
[Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
December 1993, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!